http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103417518-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103417518-B |
| titleOfInvention | Oxidized resveratrol is as the application of preparation tumor |
| abstract | The invention discloses the application of oxidized resveratrol in the medicine of preparation treatment tumor.In vitro cell experiment shows that oxidized resveratrol all has good growth inhibited effect to this 7 strain of Leukemia K562 cell, Proliferation of Human Ovarian Cell SK-OV-3, human breast cancer cell line Bcap-37, human liver cancer cells Hep G2, human lung cancer cell A549, KB cell HNE-1 and human colon cancer cell SW480 humanized tumor cell line, and the IC50 value of 48 hours is between 0.047 ~ 0.277mM; Especially obvious to the growth inhibited effect of human liver cancer cells Hep G2, Proliferation of Human Ovarian Cell SK-OV-3 and human breast cancer cell line Bcap-37 cell.Zoopery shows that the growth of oxidized resveratrol to mice transplantability tumor S180 sarcoma and mice transplantability tumor H22 hepatocarcinoma has obvious inhibitory action, and toxic and side effects is low. |
| priorityDate | 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.